Early treatment with convalescent plasma may reduce risk of long COVID

Findings from a nationwide, multicenter study led by Johns Hopkins Medicine and the Johns Hopkins Bloomberg School of Public Health suggest that patients with COVID-19 have less chance of developing post-COVID conditions -; commonly known as long COVID -; if they receive early treatment with plasma from convalescent (recovered) COVID patients that contain antibodies against SARS-CoV-2, the virus that causes COVID-19.

UK NICE recommends Accord’s Relugolix for prostate cancer

Relugolix offers a more convenient and flexible treatment option than injectable therapies. Credit: NICE. The UK National Institute for Health and Care Excellence (Nice) has

July 22, 2024

Relaxation interventions can be offered to lactating parents who would like to improve milk supply and increase well-being

A recent study in JAMA Pediatrics explored the utility of relaxation therapy in increasing milk production in human mothers.

May 9, 2024

Scientists weigh in on RFK Jr. as HHS secretary

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. The schedule at my YMCA recently changed

November 15, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.